Cell Cycle Inhibitors (Translational Genomics Research Institute)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCell Cycle Inhibitors (Translational Genomics Research Institute)
Drug Alias NameDPC-046UA-62784UA-62001
ClassificationSmall molecules
Mechanisms of ActionApoptosis stimulantsCell cycle inhibitors
TargetsUpdating
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTranslational Genomics Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTranslational Genomics Research Institute
Active IndicationsN/A
Inactive IndicationsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A